Bruker Corporation (BRKR)
| Market Cap | 9.34B |
| Revenue (ttm) | 1.96B |
| Net Income (ttm) | 157.50M |
| Shares Out | 153.20M |
| EPS (ttm) | 1.02 |
| PE Ratio | 59.78 |
| Forward PE | 36.63 |
| Dividend | $0.16 |
| Dividend Yield | 0.26% |
| Trading Day | February 26 |
| Last Price | $60.98 |
| Previous Close | $62.79 |
| Change ($) | -1.81 |
| Change (%) | -2.88% |
| Day's Open | 62.96 |
| Day's Range | 60.80 - 63.40 |
| Day's Volume | 657,356 |
| 52-Week Range | 30.70 - 69.92 |
MUNICH--(BUSINESS WIRE)--Nature Communications Publication by Mann & Theis Groups Harnesses the Benefits of Large-scale Peptide Collisional Cross Section (CCS) Measurement
Within Bruker's (BRKR) Nano Group Semiconductor metrology revenues have been steady with order rates improving as semi metrology equipment markets are witnessing a rebound.
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation to Present at Investor Conferences
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Announces Quarterly Dividend
Bruker's (BRKR) revenues increased 4.6% year over year to $627.5 million but declined 0.4% organically in fourth-quarter fiscal 2020.
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Reports Fourth Quarter and Fiscal Year 2020 Financial Results
Bruker (NASDAQ:BRKR) unveils its next round of earnings this Tuesday, February 16. Get prepared with Benzinga's ultimate preview for Bruker's Q4 earnings.
Bruker (BRKR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Bruker (BRKR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bruker (BRKR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Announces Date and Time of Fourth Quarter 2020 Earnings Release and Webcast
CAMBRIDGE & WETHERBY, England & BILLERICA, Mass.--(BUSINESS WIRE)--Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, announces that it has entered into a co...
4 Stocks to Watch on Rising Demand for Scientific Instruments
BOSTON, United States & REGENSBURG, Germany--(BUSINESS WIRE)--NMR diagnostics company numares and Bruker Corporation sign agreement to enable advanced metabolomics-based, AI driven clinical di...
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation to Present at the 39th Annual J.P. Morgan Healthcare Conference
BILLERICA, Mass. & ODENSE, Denmark--(BUSINESS WIRE)--Bruker and Evosep Announce Major Progress in Unbiased, Quantitative True Single-cell Proteomics
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Introduces MBT Sepsityper® Kit US IVD for Rapid and Affordable Identification of over 400 Microorganisms from Positive Blood Cultures
Bruker's (BRKR) winter four-plex panel is expected to facilitate diagnosis and patient management by facilitating the use of saliva samples as well.
NEHREN, Germany--(BUSINESS WIRE)--Bruker Launches FluoroType® SARS-CoV-2/Flu/RSV PCR Panel in Europe with CE-IVD Mark
Bruker (BRKR) is optimistic about maintaining a robust product portfolio along with its continued COVID-19-led progress.
Bruker (BRKR) reported earnings 30 days ago. What's next for the stock?
For the month, there were 13 buys including two new positions. I made the month's purchases last Friday. With the market flying high, what bargains are out there now?
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation to Participate in the Jefferies Virtual London Healthcare Conference
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Announces Quarterly Dividend
Bruker's (BRKR) third-quarter 2020 results reflect dismal performances by two of the reporting segments and geographies due to coronavirus-led business disruptions.
Bruker Corporation (BRKR) CEO Frank Laukien on Q3 2020 Results - Earnings Call Transcript
Bruker (BRKR) delivered earnings and revenue surprises of 27.27% and 5.27%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Reports Third Quarter 2020 Financial Results
On Monday, November 02, Bruker (NASDAQ: BRKR) will release its latest earnings report. Benzinga's outlook for Bruker is included in the following report.
We discuss the 13 stocks I added to my portfolio in October. I lay out the bull case for Northwest Natural as it trades near its highest dividend yield in 10 years.
Bruker (BRKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MADISON, Wisc.--(BUSINESS WIRE)--Bruker Introduces Vutara™ VXL Best-in-Class Super-Resolution Microscope and Spatial Biology Analysis Capabilities
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Announces Date and Time of Third Quarter 2020 Earnings Release and Webcast
ZUERICH--(BUSINESS WIRE)--Bruker Introduces Routine Gradient Spectroscopy and Industry-Standard PAL® Automation on High-Performance Fourier™ 80 Benchtop FT-NMR System
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Introduces PaSER™ Software for ‘Run and Done' 4D- ProteomicsTM and TIMS/PASEF Method Wins HUPO 2020 Award
Bruker (BRKR) has several Bruker NANO products that are being assembled and tested in Malaysia.
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Announces Acquisition of Integrated Proteomics Pipeline (IP2) Software Platform for Large Cohort Translational Studies
The global trade winds are shifting. That should be good news for domestic industry, and these seven manufacturing stocks in particular.
13 stocks purchased this month, and 1 sale: JD.
Bruker (BRKR) expands its multi-dimensional immune profiling by adding ChipCytometry tools via the acquisition of Canopy Biosciences.
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Announces Acquisition of Canopy Biosciences, LLC
At Bruker's (BRKR) Germany campus, the company currently offers a pilot COVID-19 at work testing program for its factory workforce.
4 Stocks to Watch on Rising Demand for Scientific Instruments
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Appoints Bonnie H.
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 2020 Wells Fargo Virtual Healthcare Conference.
Bruker (BRKR) reported earnings 30 days ago. What's next for the stock?
For higher specific detection of the SARS-CoV-2 virus, Bruker (BRKR) launches luoroType SARS-CoV-2 plus next-generation 6-plex PCR assay.
FRANKFURT, Germany--(BUSINESS WIRE)--Bruker Supports International Covid19-NMR Consortium for Structure-Function and Inhibitor Binding Investigations of SARS-CoV-2 RNA and Proteins
BILLERICA, Mass.--(BUSINESS WIRE)--Utrecht University and Bruker Announce Collaboration to Develop Methods for Studying Protein Structures and Interactions by Mass Spectrometry
Bruker's (BRKR) second-quarter 2020 results reflect dismal performance by all segments and geographies due to coronavirus-led business disruptions.
About BRKR
Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry solutions; analytical and process analysis instruments and solutions based on infrared and Raman... [Read more...]
| Industry Medical Devices | IPO Date Aug 4, 2000 |
| CEO Frank Laukien | Country United States |
| Stock Exchange NASDAQ | Ticker Symbol BRKR |
Financial Performance
In 2019, Bruker's revenue was $2.07 billion, an increase of 9.34% compared to the previous year's $1.90 billion. Earnings were $197.20 million, an increase of 9.74%.
Analyst Forecasts
According to 13 analysts, the average rating for Bruker stock is "Buy." The 12-month stock price forecast is 65.42, which is an increase of 7.28% from the latest price.